Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study
- PMID: 25057178
- PMCID: PMC4207219
- DOI: 10.1136/annrheumdis-2014-205459
Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study
Abstract
Objectives: To examine the relationship between being overweight or obese and developing rheumatoid arthritis (RA) in two large prospective cohorts, the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII).
Methods: We followed 109 896 women enrolled in NHS and 108 727 in NHSII who provided lifestyle, environmental exposure and anthropometric information through biennial questionnaires. We assessed the association between time-varying and cumulative Body Mass Index (BMI) in WHO categories of normal, overweight and obese (18.5-<25, 25.0-<30, ≥30.0 kg/m(2)) and incident RA meeting the 1987 American College of Rheumatology (ACR) criteria. We estimated HRs for overall RA and serologic subtypes with Cox regression models adjusted for potential confounders. We repeated analyses restricted to RA diagnosed at age 55 years or younger.
Results: During 2 765 195 person-years of follow-up (1976-2008) in NHS and 1 934 518 person-years (1989-2009) in NHSII, we validated 1181 incident cases of RA (826 in NHS, 355 in NHSII). There was a trend toward increased risk of all RA among overweight and obese women (HR (95% CI) 1.37 (0.95 to 1.98) and 1.37 (0.91, 2.09), p for trend=0.068). Among RA cases diagnosed at age 55 years or younger, this association appeared stronger (HR 1.45 (1.03 to 2.03) for overweight and 1.65 (1.34 to 2.05) for obese women (p trend <0.001)). Ten cumulative years of being obese, conferred a 37% increased risk of RA at younger ages (HR 1.37 (1.11 to 1.69)).
Conclusions: Risks of seropositive and seronegative RA were elevated among overweight and obese women, particularly among women diagnosed with RA at earlier ages.
Keywords: Ant-CCP; Epidemiology; Rheumatoid Arthritis; Rheumatoid Factor.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Conflict of Interest: None declared
Comment in
-
The impact of obesity on the development and progression of rheumatoid arthritis.Ann Rheum Dis. 2014 Nov;73(11):1911-3. doi: 10.1136/annrheumdis-2014-205741. Ann Rheum Dis. 2014. PMID: 25288687 No abstract available.
References
-
- Barry CL, Gollust SE, Niederdeppe J. Are Americans ready to solve the weight of the nation? N Engl J Med. 2012 Aug 2;367(5):389–391. - PubMed
-
- Obes Res. Suppl 2. Vol. 6. National Institutes of Health; 1998. Sep, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults; pp. 51S–209S. The Evidence Report. - PubMed
-
- Gualillo O, Gonzalez-Juanatey JR, Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med. 2007 Nov;17(8):275–283. - PubMed
-
- Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005 Nov;33(Pt 5):1078–1081. - PubMed
-
- Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005 Dec;183(2):308–315. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA050385/CA/NCI NIH HHS/United States
- AR049880/AR/NIAMS NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- U01 CA176726/CA/NCI NIH HHS/United States
- CA87969/CA/NCI NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- AR052403/AR/NIAMS NIH HHS/United States
- AR061362/AR/NIAMS NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- R01 AR061362/AR/NIAMS NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
- CA176726/CA/NCI NIH HHS/United States
- AR047782/AR/NIAMS NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- K24 AR066109/AR/NIAMS NIH HHS/United States
- R01 AR059073/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- AR059073/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
